Clinical trial

Characterization of the Prosocial and Prosexual Effects of GHB

NCT02342366

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention GHB 35 mg/kg p.o. Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention GHB 20 mg/kg p.o. Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Characterization of the Prosocial and Prosexual Effects of GHB

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-02-01

PhaseNA

Conditions

Depressive Disorder, Majorcandidate · MONDO: major depressive disorder

Bipolar Disorderverified · MONDO: bipolar disorder

Autistic Disorderunresolved

Interventions

GHB 35 mg/kg p.o.DRUG

GHB 20 mg/kg p.o.DRUG

Sponsors & collaborators

University of Zurichlead sponsor

University of Regensburgcollaborator

University of Salernocollaborator

University of Viennacollaborator

University of Freiburgcollaborator

Mapped research locations

ZurichSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02342366 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.